Premium
Homocysteine Impairs Endothelial Wound Healing by Activating Metabotropic Glutamate Receptor 5
Author(s) -
CHEN CHENGHUNG,
BEARD RICHARD S.,
BEARDEN SHAWN E.
Publication year - 2012
Publication title -
microcirculation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.793
H-Index - 83
eISSN - 1549-8719
pISSN - 1073-9688
DOI - 10.1111/j.1549-8719.2012.00159.x
Subject(s) - metabotropic glutamate receptor 5 , pharmacology , metabotropic glutamate receptor , wound healing , metabotropic glutamate receptor 1 , glutamate receptor , medicine , angiogenesis , chemistry , receptor , cancer research , microbiology and biotechnology , biology , immunology
Please cite this paper as: Chen C‐H, Beard RS, Bearden SE. Homocysteine impairs endothelial wound healing by activating metabotropic glutamate receptor 5. Microcirculation 19: 285–295, 2012. Abstract Objective: Hcy is an independent risk factor for cerebrovascular disease and cognitive impairment. The purpose of this study was to elucidate the role of mGluR5 in Hcy‐mediated impairment of cerebral endothelial wound repair. Methods: Mouse CMVECs (bEnd.3) were used in conjunction with directed pharmacology and shRNA. AutoDock was used to simulate the docking of ligand–receptor interactions. Results: Hcy (20 μ M) significantly increased Cx43‐pS368 by mGluR5‐ and PKC‐dependent mechanisms. Hcy attenuated wound repair by an mGluR5‐dependent mechanism over the six‐day study period but did not alter cell proliferation in a proliferation assay, suggesting that the attenuation of wound repair may be due to dysfunctional migration in HHcy. Hcy increased the expression of Cx43 and Cx43‐pS368 at the wound edge by activating mGluR5. Direct activation of mGluR5, using the specific agonist CHPG, was sufficient to reproduce the results whereas KO of mGluR5 with shRNA, or inhibition with MPEP, blocked the response to Hcy. Conclusions: Inhibition of mGluR5 activation could be a novel strategy for promoting endothelial wound repair in patients with HHcy. Activation of mGluR5 may be a viable strategy for disrupting angiogenesis.